A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy

From MaRDI portal
Publication:3616427

DOI10.1093/imammb/dqn024zbMath1157.92024OpenAlexW2073009824WikidataQ51862275 ScholiaQ51862275MaRDI QIDQ3616427

Alberto d'Onofrio, Alberto Gandolfi

Publication date: 25 March 2009

Published in: Mathematical Medicine and Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1093/imammb/dqn024




Related Items (22)

Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapyUnderstanding the antiangiogenic effect of metronomic chemotherapy through a simple mathematical modelMathematical model of cancer growth controled by metronomic chemotherapiesModeling tumor growth inhibition and toxicity outcome after administration of anticancer agents in xenograft mice: a dynamic energy budget (DEB) approachLocal controllability and optimal control for a model of combined anticancer therapy with control delaysSensitivity of combined chemo- and antiangiogenic therapy results in different models describing cancer growthWKB theory of large deviations in stochastic populationsTraveling waves and free boundaries arising in tumor angiogenesisThe nature of Hopf bifurcation for the Gompertz model with delaysMulti-input optimal control problems for combined tumor anti-angiogenic and radiotherapy treatmentsAnalysis of the Hopf bifurcation for the family of angiogenesis models. II: The case of two nonzero unequal delaysStability analysis of the family of tumour angiogenesis models with distributed time delaysTime delay in physiological systems: analyzing and modeling its impactChemotherapy of vascularised tumours: role of vessel density and the effect of vascular ``pruningDelay Differential Equations in Bio-PopulationsAngiogenesis inhibition and tumor-immune interactions with chemotherapy by a control set-valued methodA generalization of Gompertz law compatible with the Gyllenberg-Webb theory for tumour growthAnalysis of the Hopf bifurcation for the family of angiogenesis modelsNonlinear dynamics in tumor-immune system interaction models with delaysOptimisation of Cancer Drug Treatments Using Cell Population DynamicsTumor Development Under Combination Treatments with Anti-angiogenic TherapiesOn optimal delivery of combination therapy for tumors




This page was built for publication: A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy